Less Ads, More Data, More Tools Register for FREE

Pin to quick pickseEnergy Group Regulatory News (EAAS)

Share Price Information for eEnergy Group (EAAS)

Share Price is delayed by 15 minutes
Get Live Data
4.95    -0.10 (-1.98%)
Bid:
4.90
Ask:
5.00
Spread: 0.10 (2.041%)
Market Cap: £19.17m
EAAS Live PriceLast checked at - London Stock Exchange

Intraday eEnergy Group Share Chart

Licence Agreement with Accudo Metals

25 Aug 2016 14:58

RNS Number : 1731I
Alexander Mining PLC
25 August 2016
 

 

25 August 2016

Alexander Mining plc

("Alexander" or the "Company")

Licence Agreement with Accudo Metals Pty. Ltd. for Projects in Australia

· Leaching technology licence agreed with Accudo for projects in Australia

· Attractive royalty and licence fee payments to Alexander

· Accudo is well financed and has excellent mining industry experience and expertise

· First stage testwork in Australia on highly attractive first target copper project underway

Alexander Mining plc is delighted to report that its wholly owned subsidiary, MetaLeach Limited ("MetaLeach"), has executed a licence agreement ("Licence Agreement") with Accudo Metals Pty. Ltd. ("Accudo"), a new Australian company which has been established to exploit Alexander's proprietary leaching technologies ("Leaching Technologies").

Accudo is funded by sophisticated investors and clients of BlueMount Capital ("BlueMount"), a national mid-tier Australian investment bank. Pre-funding for test work and a full Scoping Study on the first targeted opportunity has been committed. Subject to the Scoping Study being positive, Accudo foundation funders and BlueMount clients will fund a detailed feasibility study.

MetaLeach has granted Accudo an exclusive licence for up to five mining projects (each a "Project") in Australia to use its Leaching Technologies, subject to securing commercial terms with the Project owners, on the following terms:

1. Royalty

Alexander will receive a royalty of 3.5 per cent. ("Royalty") for product produced using the Leaching Technologies ("Plant Product"). The Royalty to be calculated either on the gross value of London Metal Exchange Grade copper or zinc cathode ("Sold Product") or, for any other Plant Product which has been sold and for which payment is received or entitled to be received ("Sold Product").

2. Project Payments

In addition to the Royalty, the Licensee shall pay MetaLeach progress payments for each Project as follows:

a. AU$250,000 on the completion of a Definitive Feasibility Study for each Project that clearly establishes the technical, economic and financial feasibility of the Project and the use of the Leaching Technologies in Processing Operations with respect to a Plant located in the particular Project Tenements subject to this Licence Agreement;

b. AU$250,000 within seven calendar days of the first commercial sale and shipment of Plant Product utilising the Leaching Technologies; and

c. AU$250,000 three months after the first sale and shipment of Plant Product utilising the Leaching Technologies.

3. Grant of Option

Conditional upon the payment by the Licensee to MetaLeach of the payments set out below the Licensee shall have the Option to convert the non-exclusive component of the Licence into an exclusive Licence (exclusions excepted for any Licence Agreement(s) already executed with third parties at the time of the Option exercise) for the use of the Leaching Technologies in Australia.

Exercise of the Option is conditional upon the Licensee commencing and funding, on standard commercial terms, technical work with MetaLeach and commencing with a feasibility study for the Leaching Technology on the first Project within one year from the date of execution of the Licence Agreement, and the following payment(s) to MetaLeach:

 

a) at any time within 12 months from the date of execution of the Licence Agreement: AU$850,000; or

 

b) on reaching the point where, for the first Project selected, a Licence Fee payment of AU$250,000 is due to MetaLeach as above in 2(a) and within 20 working days therefrom: a payment AU$1,350,000.

Martin Rosser, Chief Executive Officer, said: "We are delighted to have signed this agreement with Accudo which is well financed and intent upon rigorously evaluating the use of Alexander's Leaching Technologies in Australia. We have been in detailed discussion with them about a range of identified potential projects of interest and we look forward to developments with optimism."

Accudo director Saliba Sassine said: "Accudo is pleased to have entered into this ground-breaking agreement for both parties. The Company is excited about the prospects and testing the technology on targeted ores."

Background on Accudo 

Accudo is a special purpose vehicle established to hold granted licences for the MetaLeach technologies and to test the Leaching Technologies on target ore bodies with a view to taking these into commercial production. The company will pursue these projects in a systematic manner and subject them to detailed testing and definitive feasibility studies ahead of commercial production. The privately-held company is funded by sophisticated investors and clients of BlueMount Capital, a national mid-tier Australian investment bank. BlueMount Capital specialises in corporate finance, including IPO, M&A, MBO and cross border transactions (www.bluemountcapital.com).

This announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

ENDS

For further information, please contact:

 

Martin Rosser

Chief Executive

Mobile: +44 (0) 7770 865 341

 

 

Matt Sutcliffe

Executive Chairman

Mobile: +44 (0) 7887 930 758

 

 

Alexander Mining plc

Tel: +44 (0) 20 7078 9566

Email: mail@alexandermining.com

Website: www.alexandermining.com

 

 

 

Northland Capital Partners Limited 

Matthew Johnson / Gerry Beaney

+44 (0) 20 3861 6625

(Corporate Finance)

John Howes / Abigail Wayne

(Corporate Broking)

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRBXGDISUDBGLU
Date   Source Headline
8th Jun 202612:00 pmRNSBoard Change
1st Jun 20267:00 amRNSPublication of AR, Notice of AGM and Board Update
18th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSBoard changes
30th Apr 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
16th Apr 20267:00 amRNSQ1 Trading Update, Revenue Recognition & Outlook
4th Mar 20267:00 amRNS-RContract wins
23rd Feb 20267:00 amRNSLoan Agreement
23rd Jan 20267:00 amRNSTrading Update
22nd Jan 20267:00 amRNSLaunch of new funding solution and first contract
19th Jan 20267:00 amRNSAppointment of Non-Executive Director
15th Dec 20257:00 amRNSFY Trading Update
27th Nov 20257:00 amRNSDirectorate change
17th Nov 20253:20 pmRNSAward of Options
12th Nov 20254:38 pmRNSSolar Agreement, Loan Agreement, Grant of Warrants
29th Oct 202511:39 amRNSHolding(s) in Company
27th Oct 20257:00 amRNS-RLargest EV Charging Project to Date with NHS
23rd Oct 20252:10 pmRNSHolding(s) in Company
20th Oct 20251:28 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSPreferred supplier for major solar contract
22nd Aug 20253:04 pmRNSHolding(s) in Company
21st Aug 20253:09 pmRNSHolding(s) in Company
19th Aug 202510:50 amRNSHolding(s) in Company
7th Aug 202512:13 pmRNSHolding(s) in Company
31st Jul 20255:17 pmRNSResult of AGM
22nd Jul 20257:00 amRNSUnaudited HY Results - Six Months Ended 30.06.25
3rd Jul 202510:46 amRNSNotice of AGM
30th Jun 20257:00 amRNSNotice of Results
13th Jun 20259:30 amRNSNotice of FY Results and Investor Presentation
3rd Jun 20259:25 amRNSHolding(s) in Company
20th May 202511:10 amRNSHolding(s) in Company
16th May 20257:00 amRNS£100m Partnership with Redaptive
7th Apr 20257:00 amRNS-RFramework win
26th Mar 20257:00 amRNS-RLaunch of SolarLife
24th Mar 20257:00 amRNS-RContracts wins and appointment to a Framework
11th Mar 20257:00 amRNS-RContract Wins
12th Feb 202511:17 amRNSHolding(s) in Company
3rd Feb 20257:00 amRNS-RInvestor Meet Company Presentation
30th Jan 20257:00 amRNSTrading update
19th Dec 20241:45 pmRNSAward of Options and PDMR Transactions
28th Nov 20247:00 amRNS-RLED Conversion Contract in Further Education
15th Oct 202410:45 amRNSHolding(s) in Company
1st Oct 20247:00 amRNSDirector appointment - additional information
30th Sep 20247:00 amRNSResults for the six months ended 30 June 2024
6th Sep 20247:00 amRNSHolding(s) in Company
8th Aug 20247:00 amRNSInvestor Presentations
26th Jul 20247:00 amRNSH1 24 Trading Update
28th Jun 20243:03 pmRNSResult of AGM
13th Jun 20247:00 amRNSNotice of General Meeting
30th Apr 20247:01 amRNSFinal Results for the 18 months ended 31 Dec 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.